Table of Contents
Chapter 1. Global Digital Neuro Biomarkers Market Executive Summary
1.1. Global Digital Neuro Biomarkers Market Size & Forecast (2024-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Type
1.3.2. By Clinical Practice
1.3.3. By End Use
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Digital Neuro Biomarkers Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Digital Neuro Biomarkers Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Chronic Neurological Disorders
3.1.2. Technological Advancements in Digital Health Tools
3.2. Market Challenges
3.2.1. Data Privacy and Security Concerns
3.2.2. Regulatory Complexities
3.3. Market Opportunities
3.3.1. Growing Focus on Personalized Medicine
3.3.2. Increasing Adoption of Remote Patient Monitoring
Chapter 4. Global Digital Neuro Biomarkers Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Digital Neuro Biomarkers Market Size & Forecasts by Type 2024-2032
5.1. Segment Dashboard
5.2. Global Digital Neuro Biomarkers Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Million)
5.2.1. Wearable
5.2.2. Mobile-based Applications
5.2.3. Sensors
5.2.4. Others
Chapter 6. Global Digital Neuro Biomarkers Market Size & Forecasts by Clinical Practice 2024-2032
6.1. Segment Dashboard
6.2. Global Digital Neuro Biomarkers Market: Clinical Practice Revenue Trend Analysis, 2022 & 2032 (USD Million)
6.2.1. Diagnostic Digital Neuro Biomarkers
6.2.2. Monitoring Digital Neuro Biomarkers
6.2.3. Predictive and Prognostic Digital Neuro Biomarkers
6.2.4. Others
Chapter 7. Global Digital Neuro Biomarkers Market Size & Forecasts by End Use 2024-2032
7.1. Segment Dashboard
7.2. Global Digital Neuro Biomarkers Market: End Use Revenue Trend Analysis, 2022 & 2032 (USD Million)
7.2.1. Healthcare Companies
7.2.2. Healthcare Providers
7.2.3. Payers
7.2.4. Others
Chapter 8. Global Digital Neuro Biomarkers Market Size & Forecasts by Region 2024-2032
8.1. North America Digital Neuro Biomarkers Market
8.1.1. U.S. Digital Neuro Biomarkers Market
8.1.1.1. Type breakdown size & forecasts, 2024-2032
8.1.1.2. Clinical Practice breakdown size & forecasts, 2024-2032
8.1.2. Canada Digital Neuro Biomarkers Market
8.2. Europe Digital Neuro Biomarkers Market
8.2.1. U.K. Digital Neuro Biomarkers Market
8.2.2. Germany Digital Neuro Biomarkers Market
8.2.3. France Digital Neuro Biomarkers Market
8.2.4. Spain Digital Neuro Biomarkers Market
8.2.5. Italy Digital Neuro Biomarkers Market
8.2.6. Rest of Europe Digital Neuro Biomarkers Market
8.3. Asia Pacific Digital Neuro Biomarkers Market
8.3.1. China Digital Neuro Biomarkers Market
8.3.2. India Digital Neuro Biomarkers Market
8.3.3. Japan Digital Neuro Biomarkers Market
8.3.4. Australia Digital Neuro Biomarkers Market
8.3.5. South Korea Digital Neuro Biomarkers Market
8.3.6. Rest of Asia Pacific Digital Neuro Biomarkers Market
8.4. Latin America Digital Neuro Biomarkers Market
8.4.1. Brazil Digital Neuro Biomarkers Market
8.4.2. Mexico Digital Neuro Biomarkers Market
8.4.3. Rest of Latin America Digital Neuro Biomarkers Market
8.5. Middle East & Africa Digital Neuro Biomarkers Market
8.5.1. Saudi Arabia Digital Neuro Biomarkers Market
8.5.2. South Africa Digital Neuro Biomarkers Market
8.5.3. Rest of Middle East & Africa Digital Neuro Biomarkers Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Altoida Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Koneksa
9.3.3. Biogen Inc.
9.3.4. Roche (Navify)
9.3.5. NeuraMetrix
9.3.6. Merck KGaA
9.3.7. Linus Health
9.3.8. Neurotrack Technologies, Inc.
9.3.9. Huma
9.3.10. NeuraLight
9.3.11. Cumulus Neuroscience
9.3.12. NeuroSense Therapeutics Ltd.
9.3.13. Verily Life Sciences LLC
9.3.14. Head Diagnostics
9.3.15. Revibe Technologies
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes